131 related articles for article (PubMed ID: 35593731)
1. Outcomes of pancreatic cancer with liver oligometastasis.
Takeda T; Sasaki T; Okamoto T; Kasuga A; Matsuyama M; Ozaka M; Inoue Y; Takahashi Y; Saiura A; Sasahira N
J Hepatobiliary Pancreat Sci; 2023 Feb; 30(2):229-239. PubMed ID: 35593731
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of lung oligometastasis in pancreatic cancer.
Takeda T; Sasaki T; Ichinose J; Inoue Y; Okamoto T; Mie T; Furukawa T; Kasuga A; Oba A; Matsuura Y; Nakao M; Ozaka M; Mun M; Takahashi Y; Sasahira N
Jpn J Clin Oncol; 2023 Dec; 53(12):1144-1152. PubMed ID: 37609670
[TBL] [Abstract][Full Text] [Related]
3. Outcomes and Prognostic Analysis of Surgical Resection for Oligometastasis from Hepatocellular Carcinoma.
Oshita KO; Kobayashi T; Tadokoro T; Namba Y; Fukuhara S; Matsubara K; Takei D; Honmyo N; Kuroda S; Kawaoka T; Aikata H; Ohdan H
Anticancer Res; 2023 Nov; 43(11):5189-5196. PubMed ID: 37909959
[TBL] [Abstract][Full Text] [Related]
4. Essential updates 2021/2022: Surgical outcomes of oligometastasis in pancreatic ductal adenocarcinoma.
Yasuda S; Nagai M; Terai T; Kohara Y; Sho M
Ann Gastroenterol Surg; 2023 May; 7(3):358-366. PubMed ID: 37152775
[TBL] [Abstract][Full Text] [Related]
5. Oligometastatic status as predictor of survival in metastatic human papillomavirus-positive oropharyngeal carcinoma.
Albergotti WG; Abberbock S; Mathews F; Ferris RL; Johnson JT; Duvvuri U; Kim S
Head Neck; 2018 Aug; 40(8):1685-1690. PubMed ID: 29756301
[TBL] [Abstract][Full Text] [Related]
6. Patients with hepatic oligometastatic pancreatic body/tail ductal adenocarcinoma may benefit from synchronous resection.
Yang J; Zhang J; Lui W; Huo Y; Fu X; Yang M; Hua R; Wang L; Sun Y
HPB (Oxford); 2020 Jan; 22(1):91-101. PubMed ID: 31262486
[TBL] [Abstract][Full Text] [Related]
7. Improved oncologic outcomes by ablative radiotherapy in patients with bone metastasis from hepatocellular carcinoma.
Kim TH; Park S; Rim CH; Choi C; Seong J
J Cancer Res Clin Oncol; 2021 Sep; 147(9):2693-2700. PubMed ID: 33582874
[TBL] [Abstract][Full Text] [Related]
8. Synchronous resections of hepatic oligometastatic pancreatic cancer: Disputing a principle in a time of safe pancreatic operations in a retrospective multicenter analysis.
Tachezy M; Gebauer F; Janot M; Uhl W; Zerbi A; Montorsi M; Perinel J; Adham M; Dervenis C; Agalianos C; Malleo G; Maggino L; Stein A; Izbicki JR; Bockhorn M
Surgery; 2016 Jul; 160(1):136-144. PubMed ID: 27048934
[TBL] [Abstract][Full Text] [Related]
9. [Treatments for Pancreatic Cancer with Oligometastasis].
Furuse J
Gan To Kagaku Ryoho; 2017 Oct; 44(10):827-830. PubMed ID: 29066673
[TBL] [Abstract][Full Text] [Related]
10. Preoperative evaluation of pancreatic ductal adenocarcinoma with synchronous liver metastasis: Diagnosis and assessment of unresectability.
Shi HJ; Jin C; Fu DL
World J Gastroenterol; 2016 Dec; 22(45):10024-10037. PubMed ID: 28018110
[TBL] [Abstract][Full Text] [Related]
11. Classification for long-term survival in oligometastatic patients treated with ablative radiotherapy: A multi-institutional pooled analysis.
Hong JC; Ayala-Peacock DN; Lee J; Blackstock AW; Okunieff P; Sung MW; Weichselbaum RR; Kao J; Urbanic JJ; Milano MT; Chmura SJ; Salama JK
PLoS One; 2018; 13(4):e0195149. PubMed ID: 29649281
[TBL] [Abstract][Full Text] [Related]
12. Survival outcomes for oligometastasis in resected non-small cell lung cancer.
Shimada Y; Saji H; Kakihana M; Kajiwara N; Ohira T; Ikeda N
Asian Cardiovasc Thorac Ann; 2015 Oct; 23(8):937-44. PubMed ID: 26207006
[TBL] [Abstract][Full Text] [Related]
13. [Multidisciplinary treatment and survival analysis for 497 cases of pancreatic cancer with liver metastases].
Ouyang HH; Pan ZY; Ma WD; Zhao LJ; Zhang T; Liu F; Quan MM
Zhonghua Yi Xue Za Zhi; 2016 Feb; 96(6):425-30. PubMed ID: 26875916
[TBL] [Abstract][Full Text] [Related]
14. Improved prognosis of pancreatic cancer patients with peritoneal metastasis.
Takeda T; Sasaki T; Mie T; Furukawa T; Yamada Y; Kasuga A; Matsuyama M; Ozaka M; Sasahira N
Pancreatology; 2021 Aug; 21(5):903-911. PubMed ID: 33766484
[TBL] [Abstract][Full Text] [Related]
15. Oligometastasis scoring system for predicting survival of patients with colorectal liver metastasis after hepatectomy.
Inoue H; Kawaguchi T; Ikoma H; Morimura R; Yamamoto Y; Ochiai T; Shimizu H; Arita T; Konishi H; Shiozaki A; Kuriu Y; Kubota T; Fujiwara H; Okamoto K; Takahashi H; Takabe K; Tsung A; Otsuji E
J Surg Oncol; 2021 Oct; 124(5):791-800. PubMed ID: 34196000
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous Radiofrequency Ablation for Metachronous Hepatic Metastases after Curative Resection of Pancreatic Adenocarcinoma.
Lee SJ; Kim JH; Kim SY; Won HJ; Shin YM; Kim PN
Korean J Radiol; 2020 Mar; 21(3):316-324. PubMed ID: 32090524
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in patients with metastatic or recurrent pancreatic cancer treated with first-line nab-paclitaxel plus gemcitabine: implication of inflammation-based scores.
Hwang I; Kang J; Ip HNN; Jeong JH; Kim KP; Chang HM; Yoo C; Ryoo BY
Invest New Drugs; 2019 Jun; 37(3):584-590. PubMed ID: 30324344
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcomes in radically treated synchronous vs. metachronous oligometastatic non-small-cell lung cancer.
Fleckenstein J; Petroff A; Schäfers HJ; Wehler T; Schöpe J; Rübe C
BMC Cancer; 2016 Jun; 16():348. PubMed ID: 27255302
[TBL] [Abstract][Full Text] [Related]
19. Long-term survival after resection of pancreatic cancer: a single-center retrospective analysis.
Yamamoto T; Yagi S; Kinoshita H; Sakamoto Y; Okada K; Uryuhara K; Morimoto T; Kaihara S; Hosotani R
World J Gastroenterol; 2015 Jan; 21(1):262-8. PubMed ID: 25574100
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Factors After Pancreatectomy for Pancreatic Cancer Initially Metastatic to the Liver.
Frigerio I; Malleo G; de Pastena M; Deiro G; Surci N; Scopelliti F; Esposito A; Regi P; Giardino A; Allegrini V; Bassi C; Girelli R; Salvia R; Butturini G
Ann Surg Oncol; 2022 Dec; 29(13):8503-8510. PubMed ID: 35976466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
